M. Ruizortega et al., PLATELET-ACTIVATING-FACTOR STIMULATES GENE-EXPRESSION AND SYNTHESIS OF MATRIX PROTEINS IN CULTURED RAT AND HUMAN MESANGIAL CELLS - ROLE OF TGF-BETA, Journal of the American Society of Nephrology, 8(8), 1997, pp. 1266-1275
Platelet-activating factor (PAF) is a potent inflammatory mediator tha
t participates in the pathogenesis of proteinuria and glomerular damag
e. However, the role of this lipid in glomerular sclerosis remains unk
nown. This study examines the effect of PAF on the regulation of extra
cellular matrix proteins by rat and human mesangial cells. PAF increas
ed in a dose-dependent manner the gene expression of fibronectin and t
ype IV collagen, but not type I collagen. Moreover, an increase in cel
l-associated and soluble fibronectin synthesis was also seen. These ef
fects were abolished by BN52021 and WEB2086, two different PAF recepto
r antagonists. Because transforming growth factor (TGF)-beta has been
considered a profibrogenic cytokine, this study also evaluated whether
PAF effects might be mediated by the production of endogenous TGF-bet
a. PAF caused an increase in TGF-beta 1 mRNA expression (by a protein
kinase C-dependent pathway) and TGF-beta activity. Moreover, PAF-induc
ed fibronectin synthesis was totally abolished when an anti-TGF-beta-n
eutralizing antibody was added to the culture medium, suggesting that
PAF stimulates fibronectin synthesis, at least in part, through the in
duction of TGF-beta. Addition of cycloheximide, a protein synthesis in
hibitor, upregulated PAF-induced fibronectin mRNA expression but downr
egulated PAF-induced TGF-beta 1 gene expression, suggesting the existe
nce of different regulatory transcriptional factors of the two protein
s. These results suggest that PAF may be implicated in matrix accumula
tion during renal injury and therefore contribute to the pathogenesis
of glomerulosclerosis.